Association of COVID-19 with: age and medical comorbidities

Authors

DOI:

https://doi.org/10.33448/rsd-v9i10.8285

Keywords:

Covid-19; Comorbidities; Vulnerability and Hearth; Streaming; Symptoms.

Abstract

Introdution: The new coronavirus is called SARS-CoV-2, however it causes Severe Acute Respiratory Syndrome (SARS). This virus is easily transmitted from person to person through contact with contaminated surfaces, as well as through aerosols, this according to the World Health Organization (WHO), but it is non-definitive evidence, and which is likely to be more propitious in places with poor ventilation and crowding. It results from symptoms such as: fever, cough, fatigue, dyspnoea, loss of smell and taste; and less frequent headache, throat and diarrhea. Objective: to analyze the association between worsening comorbidities, age and SARS-CoV-2 infection. Methodology: this research is of qualitative / quantitative property, with an exploratory and descriptive attribute, fostered through secondary data extracted from scientific articles from indexing sources, in the year 2016, 2018 and 2020, with language: English, Spanish and Portuguese. Results: it aims to understand the disease through statistical data through the amount of death by COVID-19, age group, the most prominent comorbidity, the most notified sex, and comparisons between deaths in Brazil due to neoplasms (breast, prostate) and deaths from cardiomyopathies, diabetes, obesity, COVID-19 and unspecified SRAG. Final considerations: Therefore, the best ways to prevent this pathology is social isolation, and to avoid possible agglomerations, since the gradual growth of deaths by COVID-19 has a great relationship both with the present comorbidities and with advanced age, therefore, people at risk should redouble their care.

References

Badawi, A., & Ryoo, S. G. (2016). Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus (MERS-CoV): a systematic review and meta-analysis. International Journal of Infectious Diseases, 49, 129-133.

Brasil. Ministério da Saúde (2020). Diabetes, hipertensão e obesidade avançam entre os brasileiros. Disponível em: https://www.saude.gov.br/noticias/agencia-saude/46982-diabetes-hipertensao-e-obesidade-avancam-entre-os-brasileiros-3

Chakraborty, M., & Pandey, M. (2020). Caring for cancer patients in the Covid pandemic: choosing between the devil and deep sea. World journal of surgical oncology, 18(1), 220. https://doi.org/10.1186/s12957-020-02002-7

Costa, T. R. M., Correia, R. S., dos Santos Silva, P. H., Barbosa, G. S. L., de Oliveira, L. M., da Cruz, V. T., ... & da Silva Júnior, A. P. (2020). A obesidade como coeficiente no agravamento de pacientes acometidos por COVID-19. Research, Society and Development, 9(9), e395997304-e395997304.

Fang, L., Karakiulakis, G., & Roth, M. (2020). Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?. The Lancet. Respiratory Medicine, 8(4), e21.

Ferreira, L. K., Meireles, J. F. F., Ferreira, M. E. C. (2018). Avaliação do estilo e qualidade de vida em idosos: uma revisão de literatura. Rev. Bras. Geriatr. Gerontol, 21(5), 639- 651.

Godri Pollitt, K. J., Peccia, J., Ko, A. I., Kaminski, N., Dela Cruz, C. S., Nebert, D. W., Reichardt, J., Thompson, D. C., & Vasiliou, V. (2020). COVID-19 vulnerability: the potential impact of genetic susceptibility and airborne transmission. Human genomics, 14(1), 17. https://doi.org/10.1186/s40246-020-00267-3

Jin, J. M., Bai, P., He, W., Wu, F., Liu, X. F., Han, D. M. & Yang, J. K. (2020). Gender differences in patients with COVID-19: Focus on severity and mortality. Frontiers in Public Health, 8, 152.

Khatamzas, E., Rothe, C., & Kroidl, I. (2020). COVID-19 aus Sicht der Infektiologie [COVID-19: Questions and answers from infectiology]. Deutsche medizinische Wochenschrift (1946), 145(15), 1051–1056. https://doi.org/10.1055/a-1164-3960e.

Lima, C. M. A. D. O. (2020). Informações sobre o novo coronavírus (COVID-19). Radiologia Brasileira, 53(2), V-VI.

Lima, F. L. O., Gomes, L. N. L., dos Santos, C. S. C., & de Oliveira, G. A. L. (2020). Diagnóstico da COVID-19: importância dos testes laboratoriais e dos exames de imagem. Research, Society and Development, 9(9), e259997162-e259997162.

McIntosh, K., Hirsch, M. S., & Bloom, A. (2020). Coronavirus disease 2019 (COVID-19). UpToDate Hirsch MS Bloom, 5.

Niquini, R. P., Lana, R. M., Pacheco, A. G., Cruz, O. G., Coelho, F. C., Carvalho, L. M., ... & Bastos, L. S. (2020). SRAG por COVID-19 no Brasil: descrição e comparação de características demográficas e comorbidades com SRAG por influenza e com a população geral. Cadernos de Saúde Pública, 36, e00149420.

Paules, C. I., Marston, H. D., & Fauci, A. S. (2020). Coronavirus infections more than just the common cold. Jama, 323(8), 707-708.

Sifuentes-Rodríguez, E., & Palacios-Reyes, D. (2020). COVID-19: O surto causado por um novo coronavírus. COVID-19: la epidemia causada por un nuevo coronavirus. Boletin medico del Hospital Infantil de Mexico , 77 (2), 47-53. https://doi.org/10.24875/BMHIM.20000039

Sinan. Sistema de Informação de Agravos de Notificação (2020). Disponível em: http://sinan.saude.gov.br/sinan/login/login.jsf

Souza Oliveira, E., & de Morais, A. C. L. N. (2020). Covid-19: uma pandemia que alerta à população. InterAmerican Journal of Medicine and Health, 3, 1-7.

Zheng, Y. Y., Ma, Y. T., Zhang. J. Y., & Xia, X. (2020). COVID-19 and the cardiovascular system. Nature Reviews Cardiology, 17(5), 259-260.

Published

20/09/2020

How to Cite

MERCÊS, S. O. das .; LIMA, F. L. O.; VASCONCELLOS NETO, J. R. T. de . Association of COVID-19 with: age and medical comorbidities . Research, Society and Development, [S. l.], v. 9, n. 10, p. e1299108285, 2020. DOI: 10.33448/rsd-v9i10.8285. Disponível em: https://rsdjournal.org/index.php/rsd/article/view/8285. Acesso em: 7 feb. 2023.

Issue

Section

Health Sciences